Analysts cut Envision price target: 4 points

Bank of America reduced its price target on Envision healthcare from $72 to $60 earlier this week, according to Dispatch Tribunal.

Advertisement

Here are four key points:

1. The firm has a “buy” rating on Envision shares.

2. On Aug. 24, Jefferies set a $71 price target on Envision shares.

3. Envision shares have a 50-day moving average of $46.95 and 200-day moving average of $54.97.

4. The company’s market cap is $4.88 billion.

More articles on surgery centers:
Hospital surgery center scrutinized for increased case load — board considers CON review
Illinois hospital breaks ground on $95M surgery center — 3 insights
USPI, Montana health system open surgery center; USPI/Tenet adds 3 centers in 8-month period & more: 4 ASC company key notes

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Register to Attend Webinar

Is ambulatory care healthcare’s big margin engine? 4 leaders weigh in

Wednesday, July 29
1:00 PM - 2:00 PM CDT

Presenters: Joe Ganley, athenahealthJeffrey Flynn, CASC, Gramercy Surgery CenterBryan Tsao, Access Center, Loma Linda University HealthJason Zepeda, Northridge Hospital Medical Center, CommonSpirit HealthGreg DeConciliis, PA-C, CASC, Boston Out­Patient Surgical Suites

Advertisement

Next Up in ASC Transactions & Valuation Issues

Advertisement

Comments are closed.